文献
J-GLOBAL ID:201802219541575568
整理番号:18A1027065
中皮腫(Nibit-Meso-1)患者におけるdulvalumabと併用したトレメリムマブ: オープンラベル,非無作為化,第2相試験【JST・京大機械翻訳】
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study
著者 (12件):
Calabro Luana
(Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy)
,
Morra Aldo
(Euganea Medica Radiology Center, Padua, Italy)
,
Giannarelli Diana
(Regina Elena National Cancer Institute, Rome, Italy)
,
Amato Giovanni
(Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy)
,
D’Incecco Armida
(Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy)
,
Covre Alessia
(Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy)
,
Lewis Arthur
(Translational Sciences, Pathology, MedImmune, Granta Park, Cambridge, UK)
,
Rebelatto Marlon C
(MedImmune, Gaithersburg, MD, USA)
,
Danielli Riccardo
(Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy)
,
Altomonte Maresa
(Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy)
,
Di Giacomo Anna Maria
(Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy)
,
Maio Michele
(Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy)
資料名:
Lancet Respiratory Medicine
(Lancet Respiratory Medicine)
巻:
6
号:
6
ページ:
451-460
発行年:
2018年
JST資料番号:
W3111A
ISSN:
2213-2600
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)